IMPORTANCE At present, no reliable predictors exist to distinguish future responders from nonresponders to treatment during the first episode of psychosis. Among potential neuroimaging predictors of treatment response, gyrification represents an important marker of the integrity of normal cortical development that may characterize, already at illness onset, a subgroup of patients with particularly poor outcome.OBJECTIVE To determine whether patients with first-episode psychosis who do not respond to 12 weeks of antipsychotic treatment already have significant gyrification defects at illness onset.DESIGN Case-control study with 12 weeks' longitudinal follow-up to determine treatment response.SETTING Secondary psychiatric services in an inner-city area (South London, England).PARTICIPANTS A total of 126 subjects, including 80 patients presenting with first-episode psychosis and 46 healthy controls. Patients were scanned at the outset and received various antipsychotic medications in a naturalistic clinical setting. They were followed up for 12 weeks and classified as responders or nonresponders if they reached criteria for symptom remission, evaluated with the Psychiatric and Personal History Schedule.OBSERVATION Patients were exposed to naturalistic antipsychotic treatment for 12 weeks following a magnetic resonance imaging scan. MAIN OUTCOMES AND MEASURESCortical gyrification was assessed using local gyrification index in a vertexwise fashion across the entire cortical surface with correction for multiple testing using permutation analysis. Differences in local gyrification index were assessed between responders, nonresponders, and healthy controls. The effect of diagnosis (affective vs nonaffective psychosis) on the local gyrification index was also investigated in responders and nonresponders.RESULTS Patients with first-episode psychosis showed a significant reduction in gyrification (hypogyria) across multiple brain regions compared with healthy controls. Interestingly, nonresponders showed prominent hypogyria at bilateral insular, left frontal, and right temporal regions when compared with responders (all clusters significant at P < .05). These effects were present for both affective and nonaffective psychoses.CONCLUSIONS AND RELEVANCE Gyrification appears to be a useful predictor of antipsychotic treatment response. Early neurodevelopmental aberrations may predict unfavorable prognosis in psychosis, irrespective of the existing diagnostic boundaries.
Background: Clozapine is the recommended antipsychotic for treatment-resistant schizophrenia (TRS) but there is significant variability between patients in the degree to which clozapine will improve symptoms. The biological basis of this variability is unknown. Although clozapine has efficacy in TRS, it can elicit adverse effects and initiation is often delayed. Identification of predictive biomarkers of clozapine response may aid initiation of clozapine treatment, as well as understanding of its mechanism of action. In this article we systematically review prospective or genetic studies of biological predictors of response to clozapine.Methods: We searched the PubMed database until 20th January 2018 for studies investigating “clozapine” AND (“response” OR “outcome”) AND “schizophrenia.” Inclusion required that studies examined a biological variable in relation to symptomatic response to clozapine. For all studies except genetic-studies, inclusion required that biological variables were measured before clozapine initiation.Results: Ninety-eight studies met the eligibility criteria and were included in the review, including neuroimaging, blood-based, cerebrospinal fluid (CSF)-based, and genetic predictors. The majority (70) are genetic studies, collectively investigating 379 different gene variants, however only three genetic variants (DRD3 Ser9Gly, HTR2A His452Tyr, and C825T GNB3) have independently replicated significant findings. Of the non-genetic variables, the most consistent predictors of a good response to clozapine are higher prefrontal cortical structural integrity and activity, and a lower ratio of the dopamine and serotonin metabolites, homovanillic acid (HVA): 5-hydroxyindoleacetic acid (5-HIAA) in CSF.Conclusions: Recommendations include that future studies should ensure adequate clozapine trial length and clozapine plasma concentrations, and may include multivariate models to increase predictive accuracy.
A preference to name stereotypically masculine before stereotypically feminine individuals explains why men are typically named before women, as on the Internet, for example (Study 1). Heterosexual couples are named with men's names first more often when such couples are imagined to conform to gender stereotypes (Studies 2 and 3). First named partners of imaginary same-sex couples are attributed more stereotypically masculine attributes (Study 4). Familiarity bounds these effects of stereotypes on name order. People name couples they know well with closer people first (Study 5), and consequently name familiar heterosexual couples with members of their own gender first (Study 6). These studies evidence a previously unknown effect of the semantics of gender stereotypes on sentence structure in the everyday use of English.William Shakespeare never wrote plays titled 'Juliet and Romeo', 'Cressida and Troilus', or 'Cleopatra and Anthony'. Had he done so, he would have flouted the prescriptions of grammarians of his time who advised that 'in speaking at the leaste, let us kepe a natural order, and set the man before the woman for manners sake' (Wilson, 1553, cited in Bodine, 1975. In the sixteenth and seventeenth centuries, English grammarians argued for the correctness, naturalness, and propriety of naming men before women on the grounds that men were the worthier and the more comprehensive sex (Bodine, 1975). Few psychologists are familiar with this history of proscribing a male-first order in binomial phrases (Malkiel, 1959) such as 'king and queen', 'his and hers', 'Mr and Mrs', or the names of romantic couples in the titles of Shakespeare's plays. To our knowledge, Brown (1986, p. 484) is the only psychologist who has ever described the prescription to name men before women as a case of sexist language.We think that Brown (1986) was right, and his recognition went unacknowledged. Specifically, we propose that while the original sexist prescriptions to name men before women may be largely forgotten, gender stereotypes continue to affect how people order the names of romantic partners. Indeed, far from being a phenomenon of the past, such [page 22] effects are evident in very modern contexts, such as Internet websites and the naming of lesbian and gay couples. Our hypothesis that gender stereotypes affect the ordering of names draws together social psychological research on gender stereotypes, cognitive, and linguistic studies of word order, and recent findings that gender stereotypes affect the ordering of visual representations of women and men in pictures (Maass,
Schizophrenia is associated with brain glutamate dysfunction, but it is currently unclear whether antipsychotic administration can reduce the extent of glutamatergic abnormality. We conducted a systematic review of proton magnetic resonance spectroscopy (1H-MRS) studies examining the effects of antipsychotic treatment on brain glutamate levels in schizophrenia. The Medline database was searched to identify relevant articles published until December 2016. Inclusion required that studies examined longitudinal changes in brain glutamate metabolites in patients with schizophrenia before and after initiation of first antipsychotic treatment or a switch in antipsychotic treatment. The searches identified eight eligible articles, with baseline and follow-up measures in a total of 168 patients. The majority of articles reported a numerical reduction in brain glutamate metabolites with antipsychotic treatment, and the estimated overall mean reduction of 6.5% in Glx (the combined signal from glutamate and glutamine) across brain regions. Significant reductions in glutamate metabolites in at least one brain region were reported in four of the eight studies, and none of the studies reported a significant glutamatergic increase after antipsychotic administration. Relationships between the degree of change in glutamate and the degree of improvement in symptoms have been inconsistent but may provide limited evidence that antipsychotic response may be associated with lower glutamate levels before treatment and a greater extent of glutamatergic reduction during treatment. Further longitudinal, prospective studies of glutamate and antipsychotic response are required to confirm these findings.
Published as Hegarty, P., Lemieux, A., & McQueen, G. (2010). Graphing the order of the sexes: Constructing, recalling, interpreting, and putting the self in gender difference graphs. Journal of Personality and Social Psychology, 98,[375][376][377][378][379][380][381][382][383][384][385][386][387][388][389][390][391]. AbstractGraphs seem to connote facts more than words or tables do. Consequently, they seem unlikely places to spot implicit sexism at work. Yet, in 6 studies (N _ 741), women and men constructed (Study 1) and recalled (Study 2) gender difference graphs with men's data first, and graphed powerful groups (Study 3) and individuals (Study 4) ahead of weaker ones. Participants who interpreted graph order as evidence of author "bias" inferred that the author graphed his or her own gender group first (Study 5). Women's, but not men's, preferences to graph men first were mitigated when participants graphed a difference between themselves and an opposite-sex friend prior to graphing gender differences (Study 6). Graph production and comprehension are affected by beliefs and suppositions about the groups represented in graphs to a greater degree than cognitive models of graph comprehension or realist models of scientific thinking have yet acknowledged.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.